☰

John Ohlfest

Affiliations: 
Neuroscience University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Neuroscience Biology, Oncology
Google:
"John Ohlfest"
Mean distance: 53433
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Stacy A. Decker grad student 2012 UMN

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Soroceanu L, Matlaf L, Khan S, et al. (2015) Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Research. 75: 3065-76
Hexum JK, Becker CM, Kempema AM, et al. (2015) Parthenolide prodrug LC-1 slows growth of intracranial glioma. Bioorganic & Medicinal Chemistry Letters. 25: 2493-5
Renner DN, Jin F, Litterman AJ, et al. (2015) Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses. Plos One. 10: e0125565
Magnus N, Meehan B, Garnier D, et al. (2014) The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis. Biochemical and Biophysical Research Communications. 454: 262-8
Olin MR, Low W, McKenna DH, et al. (2014) Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response. Journal For Immunotherapy of Cancer. 2: 4
Murphy KA, Erickson JR, Johnson CS, et al. (2014) CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma. Journal of Immunology (Baltimore, Md. : 1950). 192: 224-33
Calinescu A, Assi H, Kolb B, et al. (2014) Abstract 187: Absence of S100A9 confers survival advantage in an aggressive de novo mouse model of glioblastoma multiforme Cancer Research. 74: 187-187
Pluhar L, Olin M, Goulart M, et al. (2014) PM-17INTRACEREBRAL IFN-γ DOES NOT ENHANCE THE RESPONSE TO VACCINE IMMUNOTHERAPY FOR CANINE GLIOMA Neuro-Oncology. 16
Ohlfest JR, Zellmer DM, Panyam J, et al. (2013) Immunotoxin targeting CD133(+) breast carcinoma cells. Drug Delivery and Translational Research. 3: 195-204
Lechner MG, Karimi SS, Barry-Holson K, et al. (2013) Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 477-89
See more...